RECRUITING

Patient and Caregiver Priorities in Neuro-oncology Care

Conditions

Malignant Central Nervous System Neoplasm Metastatic Malignant Neoplasm in the Central Nervous System

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is being done to identify patient and caregiver burdens regarding their experience with diagnosis and treatment of CNS tumors. These results will help doctors find areas where patients and caregivers may need more support.

Official Title

Patient and Caregiver Priorities in Neuro-Oncology Care

Quick Facts

Study Start:2024-04-24

Study Completion:2026-04-30

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06676306

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* \* Age ≥ 18 years. * Diagnosis of primary or metastatic CNS tumor with a primary caregiver, should patient wish to involve one. * Willing and able to participate in a semi-structured interview lasting approximately 60 minutes. Dyad interviews conducted for participants who elect to involve a caregiver. * Willing and able to participate in a single follow-up interview. Dyad follow up interviews conducted for participants who elect to involve a caregiver.	* \* Uncontrolled and/or intercurrent illness which limits participation in study interview. * Vulnerable populations: pregnant or nursing persons, prisoners, or persons lacking capacity for understanding. * Unable to read and speak English. * Note: English does not need to be primary language.

Inclusion Criteria

Exclusion Criteria

* \* Age ≥ 18 years.
* Diagnosis of primary or metastatic CNS tumor with a primary caregiver, should patient wish to involve one.
* Willing and able to participate in a semi-structured interview lasting approximately 60 minutes. Dyad interviews conducted for participants who elect to involve a caregiver.
* Willing and able to participate in a single follow-up interview. Dyad follow up interviews conducted for participants who elect to involve a caregiver.

* \* Uncontrolled and/or intercurrent illness which limits participation in study interview.
* Vulnerable populations: pregnant or nursing persons, prisoners, or persons lacking capacity for understanding.
* Unable to read and speak English.
* Note: English does not need to be primary language.

Contacts and Locations

Study Contact

Clinical Trials Referral Office

CONTACT

855-776-0015

mayocliniccancerstudies@mayo.edu

Principal Investigator

Ugur T. Sener, MD

PRINCIPAL_INVESTIGATOR

Mayo Clinic in Rochester

Study Locations (Sites)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905

United States

Collaborators and Investigators

Sponsor: Mayo Clinic

Ugur T. Sener, MD, PRINCIPAL_INVESTIGATOR, Mayo Clinic in Rochester

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-04-24

Study Completion Date2026-04-30

Study Record Updates

Study Start Date2024-04-24

Study Completion Date2026-04-30

Terms related to this study

Additional Relevant MeSH Terms

Malignant Central Nervous System Neoplasm
Metastatic Malignant Neoplasm in the Central Nervous System